301103SZSE

He Ophthalmology Co., Ltd.

何氏眼科

301103

Shenzhen Stock Exchange

Follow
45 announcements tracked· Last: May 21, 2026

Key Financials

Revenue¥305.2M
Net Profit¥32.7M
ROE1.70%
Debt Ratio13.94%
Monetary Funds¥366.1M
Receivables¥37.3M
Total Shares158.0M

Announcements

45 total

Announcement on the Implementation of 2025 Annual Equity Distribution

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent Director Candidate Statement and Commitment (Feng Jun)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent Director Nominee Statement and Commitment (Feng Jun)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Independent Director Candidate Statement and Commitment (Sun Li)

Convertible BondsShareholding Change DisclosureCapital Reduction

Independent Director Nominee Statement and Commitment (Sun Li)

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Expiration of Independent Director's Term and the Re-election of Independent Directors, and Adjustment of Special Committee Members of the Board

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Legal Opinion from Beijing Zhonglun Law Firm on the 2025 Annual Shareholders' Meeting of Liaoning He’s Eye Hospital Group Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement of Resolutions from the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice of the 2026 Second Extraordinary Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement of Resolutions from the 19th Meeting of the 3rd Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the completion of the share reduction plan by shareholders holding more than 5%

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Zhongyuan Securities Co., Ltd. on the Summary Report of the First Public Offering of Shares and Listing on the Growth Enterprise Market of Liaoning He’s Ophthalmology Hospital Group Co., Ltd.

Shareholder Share IncreaseShareholding Change DisclosureCapital Reduction

2025 Annual Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

Zhongyuan Securities Co., Ltd. Special Review Opinion on the Storage and Use of Raised Funds in 2025 for Liaoning He’s Ophthalmology Hospital Group Co., Ltd.

Share PledgeShareholding Change DisclosureCapital Reduction

Announcement on the Renewal of the Accounting Firm

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Zhongyuan Securities Co., Ltd. 2025 Annual Continuous Supervision Tracking Report on Liaoning He’s Ophthalmology Hospital Group Co., Ltd.

Shareholder Share IncreaseShareholding Change DisclosureCapital Reduction

2025 Annual Board of Directors Work Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Confirmation of 2025 Annual Compensation for Directors and Senior Management and the 2026 Annual Compensation Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report (Li Hui)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report (Zhu Jie)

Convertible BondsShareholding Change DisclosureCapital Reduction

2025 Annual Independent Director Work Report (Wang Houshuang)

Convertible BondsShareholding Change DisclosureCapital Reduction

Announcement on Holding the 2025 Annual Online Performance Briefing

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Environmental, Social, and Governance (ESG) Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Zhongyuan Securities Co., Ltd. Review Opinion on Liaoning He’s Ophthalmology Hospital Group Co., Ltd. 2025 Annual Internal Control Self-Assessment Report

Share Repurchase CompletionShareholder Share IncreaseShare Pledge

Internal Control Audit Report

Share PledgeShareholding Change DisclosureCapital Reduction

2025 Annual Internal Control Self-Assessment Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Provision for Asset Impairment in 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Report on the Storage, Management, and Use of Raised Funds in 2025

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notice of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Third Board of Directors Eighteenth Meeting Resolution Announcement

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the 2025 Annual Profit Distribution Plan

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2026 First Quarter Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Verification Report on the Annual Storage and Use of Raised Funds

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

2025 Annual Audit Accountant Performance Evaluation Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Board of Directors Audit Committee Report on the Evaluation of the Accounting Firm's Performance in 2025 and the Fulfillment of Supervision Responsibilities

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Special Explanation on Non-operating Fund Occupation and Other Related Fund Transactions

Share Repurchase CompletionShare PledgeShareholding Change Disclosure

2025 Annual Non-operating Fund Occupation and Other Related Fund Transactions Summary Table

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Board of Directors Special Opinion on the Independence Assessment of Independent Directors

Share Repurchase CompletionConvertible BondsShareholding Change Disclosure

2025 Annual Report

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

2025 Annual Report Summary

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Expiration of Independent Directors' Terms

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the completion of private equity fund filing for jointly investing in an industrial fund with professional investment institutions

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Estimated Daily Related Party Transactions for 2026

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Resolution Announcement of the Seventeenth Meeting of the Third Board of Directors

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Announcement on the Chairman Acting as Board Secretary

Share Repurchase CompletionShareholding Change DisclosureCapital Reduction

Notes & Comments

Sign in to leave a comment or private note.

Loading…